Characterization of migration parameters on peripheral and central nervous system T cells following treatment of experimental allergic encephalomyelitis with CRYAB

Journal of Neuroimmunology

Volumn 259, Issue 1-2, 2013, Pages 66-74

  Oyebamiji, Adeola I ^a,c   Finlay, Trisha M ^a,c   Hough, Rachael M ^b   Hoghooghi, Vahid ^a,c   Lim, Erin Mai F ^a,c   Wong, Connie H Y ^a   Ousman, Shalina S ^a,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cell adhesion molecules; Chemokine receptors; Chemokines; Migration; Multiple sclerosis; Trafficking

Indexed keywords

ALPHA CRYSTALLIN; CD11B ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CXCL9 CHEMOKINE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 5; RECOMBINANT PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MOUSE; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALPHA-CRYSTALLIN B CHAIN; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; LYMPH NODES; MICE; MICE, 129 STRAIN; MULTIPLE SCLEROSIS; NEUROIMMUNOMODULATION; RECEPTORS, CCR6; RECEPTORS, CCR7; RECEPTORS, CXCR4; SPINAL CORD; SPLEEN;

EID: 84877627496     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.03.007     Document Type: Article

References (56)

1. Acharya M., Mukhopadhyay S., Paidassi H., Jamil T., Chow C., Kissler S., Stuart L.M., Hynes R.O., Lacy-Hulbert A. Alphav integrin expression by DCs is required for Th17 cell differentiation and development of experimental autoimmune encephalomyelitis in mice. J. Clin. Invest. 2010, 120:4445-4452.
2. Alge C.S., Priglinger S.G., Neubauer A.S., Kampik A., Zillig M., Bloemendal H., Welge-Lussen U. Retinal pigment epithelium is protected against apoptosis by alphaB-crystallin. Invest. Ophthalmol. Vis. Sci. 2002, 43:3575-3582.
3. Ambrosini E., Aloisi F. Chemokines and glial cells: a complex network in the central nervous system. Neurochem. Res. 2004, 29:1017-1038.
4. Andley U.P., Song Z., Wawrousek E.F., Fleming T.P., Bassnett S. Differential protective activity of alpha A- and alphaB-crystallin in lens epithelial cells. J. Biol. Chem. 2000, 275:36823-36831.
5. Aoyama A., Frohli E., Schafer R., Klemenz R. Alpha B-crystallin expression in mouse NIH 3T3 fibroblasts: glucocorticoid responsiveness and involvement in thermal protection. Mol. Cell. Biol. 1993, 13:1824-1835.
6. Axtell R.C., de Jong B.A., Boniface K., van der Voort L.F., Bhat R., De Sarno P., Naves R., Han M., Zhong F., Castellanos J.G., Mair R., Christakos A., Kolkowitz I., Katz L., Killestein J., Polman C.H., de Waal Malefyt R., Steinman L., Raman C. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 2010, 16:406-412.
7. Axtell R.C., Raman C., Steinman L. Type I Interferons: Beneficial in Th1 and Detrimental in Th17 Autoimmunity. Clin. Rev. Allergy Immunol. 2013, 44:114-120.
8. Bauer M., Brakebusch C., Coisne C., Sixt M., Wekerle H., Engelhardt B., Fassler R. Beta1 integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunity. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:1920-1925.
9. Benjamin I.J., Shelton J., Garry D.J., Richardson J.A. Temporospatial expression of the small HSP/alpha B-crystallin in cardiac and skeletal muscle during mouse development. Dev. Dyn. 1997, 208:75-84.
10. Bhat S.P., Nagineni C.N. Alpha B subunit of lens-specific protein alpha-crystallin is present in other ocular and non-ocular tissues. Biochem. Biophys. Res. Commun. 1989, 158:319-325.
11. Bowen M.A., Patel D.D., Li X., Modrell B., Malacko A.R., Wang W.C., Marquardt H., Neubauer M., Pesando J.M., Francke U., et al. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J. Exp. Med. 1995, 181:2213-2220.
12. Bromley S.K., Mempel T.R., Luster A.D. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat. Immunol. 2008, 9:970-980.
13. Cayrol R., Wosik K., Berard J.L., Dodelet-Devillers A., Ifergan I., Kebir H., Haqqani A.S., Kreymborg K., Krug S., Moumdjian R., Bouthillier A., Becher B., Arbour N., David S., Stanimirovic D., Prat A. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat. Immunol. 2008, 9:137-145.
14. Chabas D., Baranzini S.E., Mitchell D., Bernard C.C., Rittling S.R., Denhardt D.T., Sobel R.A., Lock C., Karpuj M., Pedotti R., Heller R., Oksenberg J.R., Steinman L. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 2001, 294:1731-1735.
15. Charo I.F., Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 2006, 354:610-621.
16. Columba-Cabezas S., Serafini B., Ambrosini E., Aloisi F. Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation. Brain Pathol. 2003, 13:38-51.
17. Fischer F.R., Santambrogio L., Luo Y., Berman M.A., Hancock W.W., Dorf M.E. Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression. J. Neuroimmunol. 2000, 110:195-208.
18. Flugel A., Berkowicz T., Ritter T., Labeur M., Jenne D.E., Li Z., Ellwart J.W., Willem M., Lassmann H., Wekerle H. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 2001, 14:547-560.
19. Holman D.W., Klein R.S., Ransohoff R.M. The blood-brain barrier, chemokines and multiple sclerosis. Biochim. Biophys. Acta 2011, 1812:220-230.
20. Horwitz J. Alpha-crystallin. Exp. Eye Res. 2003, 76:145-153.
21. Ito H., Inaguma Y., Kato K. Small heat shock proteins participate in the regulation of cellular aggregates of misfolded protein. Nihon Yakurigaku Zasshi 2003, 121:27-32.
22. Iwaki T., Iwaki A., Liem R.K., Goldman J.E. Expression of alpha B-crystallin in the developing rat kidney. Kidney Int. 1991, 40:52-56.
23. Izikson L., Klein R.S., Charo I.F., Weiner H.L., Luster A.D. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J. Exp. Med. 2000, 192:1075-1080.
24. Kamradt M.C., Chen F., Cryns V.L. The small heat shock protein alpha B-crystallin negatively regulates cytochrome c- and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation. J. Biol. Chem. 2001, 276:16059-16063.
25. Kato K., Shinohara H., Kurobe N., Goto S., Inaguma Y., Ohshima K. Immunoreactive alpha A crystallin in rat non-lenticular tissues detected with a sensitive immunoassay method. Biochim. Biophys. Acta 1991, 1080:173-180.
26. Kato K., Shinohara H., Kurobe N., Inaguma Y., Shimizu K., Ohshima K. Tissue distribution and developmental profiles of immunoreactive alpha B crystallin in the rat determined with a sensitive immunoassay system. Biochim. Biophys. Acta 1991, 1074:201-208.
27. Kivisakk P., Mahad D.J., Callahan M.K., Sikora K., Trebst C., Tucky B., Wujek J., Ravid R., Staugaitis S.M., Lassmann H., Ransohoff R.M. Expression of CCR7 in multiple sclerosis: implications for CNS immunity. Ann. Neurol. 2004, 55:627-638.
28. Kurnellas M.P., Brownell S.E., Su L., Malkovskiy A.V., Rajadas J., Dolganov G., Chopra S., Schoolnik G.K., Sobel R.A., Webster J., Ousman S.S., Becker R.A., Steinman L., Rothbard J.B. Chaperone activity of small heat shock proteins underlies therapeutic efficacy in experimental autoimmune encephalomyelitis. J. Biol. Chem. 2012, 287:36423-36434.
29. Larochelle C., Alvarez J.I., Prat A. How do immune cells overcome the blood-brain barrier in multiple sclerosis?. FEBS Lett. 2011, 585:3770-3780.
30. Ley K., Kansas G.S. Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat. Rev. Immunol. 2004, 4:325-335.
31. Liu B., Bhat M., Nagaraj R.H. AlphaB-crystallin inhibits glucose-induced apoptosis in vascular endothelial cells. Biochem. Biophys. Res. Commun. 2004, 321:254-258.
32. Lucas A.D., Chadwick N., Warren B.F., Jewell D.P., Gordon S., Powrie F., Greaves D.R. The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo. Am. J. Pathol. 2001, 158:855-866.
33. Masilamoni J.G., Jesudason E.P., Bharathi S.N., Jayakumar R. The protective effect of alpha-crystallin against acute inflammation in mice. Biochim. Biophys. Acta 2005, 1740:411-420.
34. Masilamoni J.G., Vignesh S., Kirubagaran R., Jesudason E.P., Jayakumar R. The neuroprotective efficacy of alpha-crystallin against acute inflammation in mice. Brain Res. Bull. 2005, 67:235-241.
35. Masilamoni J.G., Jesudason E.P., Baben B., Jebaraj C.E., Dhandayuthapani S., Jayakumar R. Molecular chaperone alpha-crystallin prevents detrimental effects of neuroinflammation. Biochim. Biophys. Acta 2006, 1762:284-293.
36. McCandless E.E., Wang Q., Woerner B.M., Harper J.M., Klein R.S. CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177:8053-8064.
37. McCandless E.E., Piccio L., Woerner B.M., Schmidt R.E., Rubin J.B., Cross A.H., Klein R.S. Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis. Am. J. Pathol. 2008, 172:799-808.
38. McCandless E.E., Budde M., Lees J.R., Dorsey D., Lyng E., Klein R.S. IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis. J. Immunol. 2009, 183:613-620.
39. Mehlen P., Preville X., Chareyron P., Briolay J., Klemenz R., Arrigo A.P. Constitutive expression of human hsp27, Drosophila hsp27, or human alpha B-crystallin confers resistance to TNF- and oxidative stress-induced cytotoxicity in stably transfected murine L929 fibroblasts. J. Immunol. 1995, 154:363-374.
40. Melton A.C., Bailey-Bucktrout S.L., Travis M.A., Fife B.T., Bluestone J.A., Sheppard D. Expression of alphavbeta8 integrin on dendritic cells regulates Th17 cell development and experimental autoimmune encephalomyelitis in mice. J. Clin. Invest. 2010, 120:4436-4444.
41. Miller D.H., Khan O.A., Sheremata W.A., Blumhardt L.D., Rice G.P., Libonati M.A., Willmer-Hulme A.J., Dalton C.M., Miszkiel K.A., O'Connor P.W. A controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 2003, 348:15-23.
42. Morrison L.E., Whittaker R.J., Klepper R.E., Wawrousek E.F., Glembotski C.C. Roles for alphaB-crystallin and HSPB2 in protecting the myocardium from ischemia-reperfusion-induced damage in a KO mouse model. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H847-H855.
43. Muller D.M., Pender M.P., Greer J.M. Chemokines and chemokine receptors: potential therapeutic targets in multiple sclerosis. Curr. Drug Targets Inflamm. Allergy 2004, 3:279-290.
44. Ousman S.S., Tomooka B.H., van Noort J.M., Wawrousek E.F., O'Connor K.C., Hafler D.A., Sobel R.A., Robinson W.H., Steinman L. Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination. Nature 2007, 448:474-479.
45. Rajasekaran N.S., Connell P., Christians E.S., Yan L.J., Taylor R.P., Orosz A., Zhang X.Q., Stevenson T.J., Peshock R.M., Leopold J.A., Barry W.H., Loscalzo J., Odelberg S.J., Benjamin I.J. Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice. Cell 2007, 130:427-439.
46. Ransohoff R.M. Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity 2009, 31:711-721.
47. Ray P.S., Martin J.L., Swanson E.A., Otani H., Dillmann W.H., Das D.K. Transgene overexpression of alphaB crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion. FASEB J. 2001, 15:393-402.
48. Reboldi A., Coisne C., Baumjohann D., Benvenuto F., Bottinelli D., Lira S., Uccelli A., Lanzavecchia A., Engelhardt B., Sallusto F. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 2009, 10:514-523.
49. Rossi B., Angiari S., Zenaro E., Budui S.L., Constantin G. Vascular inflammation in central nervous system diseases: adhesion receptors controlling leukocyte-endothelial interactions. J. Leukoc. Biol. 2011, 89:539-556.
50. Rothbard J.B., Zhao X., Sharpe O., Strohman M.J., Kurnellas M., Mellins E.D., Robinson W.H., Steinman L. Chaperone activity of alpha B-crystallin is responsible for its incorrect assignment as an autoantigen in multiple sclerosis. J. Immunol. 2011, 186:4263-4268.
51. Rothbard J.B., Kurnellas M.P., Brownell S., Adams C.M., Su L., Axtell R.C., Chen R., Fathman C.G., Robinson W.H., Steinman L. Therapeutic effects of systemic administration of chaperone alphaB-crystallin associated with binding proinflammatory plasma proteins. J. Biol. Chem. 2012, 287:9708-9721.
52. Rothhammer V., Heink S., Petermann F., Srivastava R., Claussen M.C., Hemmer B., Korn T. Th17 lymphocytes traffic to the central nervous system independently of alpha4 integrin expression during EAE. J. Exp. Med. 2011, 208:2465-2476.
53. Rottman J.B., Slavin A.J., Silva R., Weiner H.L., Gerard C.G., Hancock W.W. Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent. Eur. J. Immunol. 2000, 30:2372-2377.
54. Ubogu E.E., Cossoy M.B., Ransohoff R.M. The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol. Sci. 2006, 27:48-55.
55. van Noort J.M., van Sechel A.C., Bajramovic J.J., el Ouagmiri M., Polman C.H., Lassmann H., Ravid R. The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature 1995, 375:798-801.
56. Yednock T.A., Cannon C., Fritz L.C., Sanchez-Madrid F., Steinman L., Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 1992, 356:63-66.